Key | % Net Assets |
---|---|
HSBC | 8.2% |
BP | 7.0% |
Vodafone | 4.9% |
Glaxosmithkline | 4.3% |
Other | 75.6% |
Name | % Net Assets |
---|---|
HSBC | 8.2% |
BP | 7.0% |
Vodafone | 4.9% |
Glaxosmithkline | 4.3% |
Royal Dutch Shell 'A' | 4.2% |
Royal Dutch Shell 'B' | 3.2% |
AstraZeneca | 2.7% |
Rio Tinto | 2.7% |
Barclays | 2.7% |
British American Tobacco | 2.6% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
Bid | 240.30p |
Offer | 240.30p |
Currency | GBP |
Change | 2.10p |
% | 0.88% |
YTD change | 19.60p |
YTD % | 8.88% |
Fund Inception | 20/07/2007 |
---|---|
Fund Manager | n/a |
TER | 0.12 (30-Sep-2010) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.10% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research